Chromosome 5q Deletion Syndrome, also known as 5q- syndrome, is related to macrocytic anemia and leukemia, acute myeloid. An important gene associated with Chromosome 5q Deletion Syndrome is RPS14 (Ribosomal Protein S14), and among its related pathways/superpathways are Influenza Infection and SARS-CoV-1-host interactions. The drugs Tacrolimus and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and myeloid, and related phenotypes are myelodysplasia and macrocytic anemia